anti-Platelet antibody product blog
Tags: Antibody; Monoclonal Antibody; Platelet; anti-Platelet antibody;
The Platelet n/a (Catalog #MBS520404) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The Anti-Mouse Platelet, FITC (Clone AIP21) (rat IgM) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s Platelet can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the Platelet n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
anti-mouse platelet monoclonal antibody (clone AIP21) detects an unidentified antigen on mouse platelets that is not identical to CD9, GPIV or integrins. This antigen is also present on B16F10 and KN-3 cells, but not thymocytes or splenocytes. This antibody induces mouse platelet aggregation in the absence of plasma components via an FcR-independent mechanism. A dramatic increase in tyrosine phosphorylation of the 52 kDa Shc protein was observed during AIP21-mediated platelet aggregation. This antibody is suitable for use in flow cytometry and functional assays.
Presentation: 100 ug FITC conjugated Ig buffered in PBS, 0.02% NaN3 and EIA grade BSA as a stabilizing protein to bring total protein concentration to 4-5 mg/ml. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Platelet are readily searchable from our website. Different antibodies against the same target such as Platelet may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.